Fundraising

Summary by AI ^BETAClose X

NYCE International Plc has successfully raised £50,000 through the issuance of 285,714 new ordinary shares at £0.175 each, with the net proceeds designated for working capital. Following admission to the AQSE Growth Market, expected around June 7, 2026, the company's total issued share capital will increase to 10,643,311 ordinary shares. These figures are provided for shareholders to assess their notification obligations under FCA rules.

Disclaimer*

NYCE International PLC

29 April 2026

NYCE International Plc

("NYCE INTERNATIONAL", "NYCE" or the "Company")

Fundraising

NYCE International Plc (AQUIS: NYCE) is pleased to announce a fundraising (the "Fundraising"). £50,000 was raised through the issue of 285,714 new ordinary shares of £0.15 each in the Company ("Ordinary Shares") at a price of £0.175 per Ordinary Share. The net proceeds from the Fundraising will be used for working capital purposes.

Application will be made for the Ordinary Shares to be admitted to trading on the AQSE Growth Market ("Admission"). Dealings are expected to commence on or around 7 June 2026.

Following Admission, the Company's total issued and voting share capital will consist of 10,643,311 Ordinary Shares.

The above figures may be used by shareholders for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

For further information, please contact:

Nyce International Plc

Farzad Peyman-Fard, CEO

Harmen Brenninkmeijer, Chairman

enquiries@nyceint.com

Oberon Capital (AQSE Corporate Adviser, Broker)

Nick Lovering

Adam Pollock

Aimee McCusker

Tel: +44 (0) 203 179 5300

This announcement contains inside information for the purposes of Article 7 of EU Regulation No. 596/2014, which forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END